To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Did you know that a component of your blood could be used ...

Please provide your email address to receive an email when new articles are posted on . IVIG had favorable effects on skin thickening, muscle and joint pain, and gastrointestinal symptoms of systemic ...

"[O]ur study, which has the largest cohort to date, did not show an increased rate of VTEs in patients with DM on IVIG. Therefore, it is safe to start patients on this medicine as it is one of our ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

NEW YORK (Reuters Health) - Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren's syndrome ...

Intravenous immunoglobulin therapy (IVIG) is a critical treatment modality in the management of a spectrum of immunodeficiencies, autoimmune disorders, and inflammatory conditions. Derived from pooled ...

With use of intravenous immune globulin (IVIg) for the treatment of adults with dermatomyositis, a significantly higher percentage of patients experienced at least minimal improvement in disease ...

Please provide your email address to receive an email when new articles are posted on . Glucocorticoids alone demonstrate similar recovery rates as IVIG, or ...

For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy (Ig) is a cornerstone of treatment. It helps prevent serious infections, reduces hospitalizations, and supports ...

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.